Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 3300.

https://doi.org/10.1182/blood.V130.Suppl_1.3300.3300

Published: 2017

Journal Articles

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5506.

https://doi.org/10.1182/blood.V130.Suppl_1.5506.5506

Published: 2017

Journal Articles

CD34+ Cell Count and Disease Free Survival in Patients with Diffuse Large B Cell Lymphoma Who Have Received Autologous Stem Cell Transplantaion

Jaejoon KIM, Cheolwon Suh, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Moonho Kim

Blood (2017) 130 (Supplement 1): 5519.

https://doi.org/10.1182/blood.V130.Suppl_1.5519.5519

Published: 2017

Journal Articles

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Juan Du, PhD MD, Weijun Fu, MD, Jae Hoon Lee, MD PhD, Chunyang Zhang, MD, Kihyun Kim, MD, Ai Jun Liu, MD, Jin Lu, Cheolwon Suh, MD PhD, Min Kyoung Kim, MD PhD, Wenming Chen, MD, Jin Liu, Hua Jiang, MD, Jian Hou, PhD MD

Blood (2017) 130 (Supplement 1): 5409.

https://doi.org/10.1182/blood.V130.Suppl_1.5409.5409

Published: 2017

Journal Articles

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4139.

https://doi.org/10.1182/blood.V130.Suppl_1.4139.4139

Published: 2017

Journal Articles

Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma

Min Young Lee, MD PhD, Chan-jeoung Park, MD, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, MD, Jung-Hee Lee, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4400.

https://doi.org/10.1182/blood.V130.Suppl_1.4400.4400

Published: 2017

Journal Articles

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 4073.

https://doi.org/10.1182/blood.V130.Suppl_1.4073.4073

Published: 2017

Journal Articles

A Phase II Study of Brentuximab Vedotin for Relapsed or Refractory CD30-Positive Non-Hodgkin Lymphomas Other Than Anaplastic Large Cell Lymphoma

Silvia Park, Seok Jin Kim, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Jin Seok Kim, MD PhD, Hye Jin Kang, MD PhD, Hyeon-Seok Eom, Mark Hong Lee, Cheolwon Suh, MD PhD, Won Seog Kim, MD, Ph. D.

Blood (2017) 130 (Supplement 1): 4077.

https://doi.org/10.1182/blood.V130.Suppl_1.4077.4077

Published: 2017

Journal Articles

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Blood (2017) 130 (Supplement 1): 2840.

https://doi.org/10.1182/blood.V130.Suppl_1.2840.2840

Published: 2017

Journal Articles

The Absolute Lymphocyte Count Is Associated with the Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Byeong Seok Sohn, MDPhD, Jeongseok Kim, MD, Dok Hyun Yoon, MD PhD, Shin Kim, RN, Jooryung Huh, MD PhD, Sung-En Park, MD, Young Jin Yuh, MD PhD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 2803.

https://doi.org/10.1182/blood.V130.Suppl_1.2803.2803

Published: 2017

Journal Articles

the Safety and Efficacy of Pomalidomide in Combination with Cyclophosphamide and Dexamethasone (PCD) in the Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma (MM) Who Had Lenalidomide Plus Dexamethasone (LD) Following Frontline Bortezomib Combined Chemotherapy, Open-Labeled, Multicenter Phase II Study

Ho Sup Lee, MD, Chang-Ki Min, MD PhD, Kihyun Kim, Seok Jin Kim, MD PhD, Je-Jung Lee, MD PhD, Inho Kim, MD PhD, Jin Seok Kim, MD PhD, Hyeon-Seok Eom, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD, Ho-Jin Shin, MD, Yeung-Chul Mun, MD PhD, Min Kyoung Kim, MD PhD, Sung-Nam Lim, MD, Chul Won Choi, MD PhD, Hye Jin Kang, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2017) 130 (Supplement 1): 1834.

https://doi.org/10.1182/blood.V130.Suppl_1.1834.1834

Published: 2017

Journal Articles

Difference of Clinical Parameters between GCB and Non-GCB Subtype DLBCL

Moonho Kim, MD, Cheolwon Suh, MD PhD, Jaejoon KIM, Jung Yong Hong

Blood (2017) 130 (Supplement 1): 5231.

https://doi.org/10.1182/blood.V130.Suppl_1.5231.5231

Published: 2017

Journal Articles

Difference of Clinical Parameters between Limited and Advanced Stage DLBCL

Moonho Kim, Cheolwon Suh, MD PhD, Jaejoon KIM, Jung Yong Hong

Blood (2017) 130 (Supplement 1): 5238.

https://doi.org/10.1182/blood.V130.Suppl_1.5238.5238

Published: 2017

Journal Articles

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

Sung Yong Oh, Jin Seok Kim, MD PhD, Ji Hyun Lee, MD PhD, Won Seog Kim, MD, Ph. D., Seok Jin Kim, MD PhD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Won-Sik Lee, MD, Hyo Jung Kim, MD PhD, Jong-Ho Won, MD, Byeong Park, MD, Soon Il Lee, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5155.

https://doi.org/10.1182/blood.V130.Suppl_1.5155.5155

Published: 2017

Journal Articles

The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis

Kyoungmin Lee, MD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Jung Bok Lee, PhD, Shin Kim, RN, Jung Sun Park, MSc, Jooryung Huh, MD PhD, Sang Wook Lee, MD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4130.

https://doi.org/10.1182/blood.V130.Suppl_1.4130.4130

Published: 2017

Journal Articles

Unmet Needs for a Better Treatment in Patients with Peripheral T Cell Lymphoma: Data from a Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Blood (2017) 130 (Supplement 1): 4088.

https://doi.org/10.1182/blood.V130.Suppl_1.4088.4088

Published: 2017

Journal Articles

Control of Neutrophil Endothelial Transmigration By EC-18 in Chemotherapy Induced Neutropenia

Jae Wha Kim, PhD, Yong-Jae Kim, Young-Jun Kim, PhD, Sun Young Yoon, PhD, Jinseon Jeong, Young-Eun Ko, Su-Hyun Shin, Nina Yoo, Myung-Hwan Kim, MD PhD, Cheolwon Suh, MD PhD, Ki-Young Sohn, Heung-Jae Kim, PhD, Yong-Hae Han, PhD, Saeho Chong, PhD

Blood (2015) 126 (23): 2210.

https://doi.org/10.1182/blood.V126.23.2210.2210

Published: 2015

Journal Articles

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Seok Jin Kim, MD PhD, Hye Jin Kang, MD PhD, Dong-Yeop Shin, MD, Dok Hyun Yoon, Kana Sakamoto, MD, Jee Hyun Kong, MD, Young Hyeh Ko, MD PhD, Kengo Takeuchi, MD PhD, Cheolwon Suh, MD, PhD, Won Seog Kim, MD PhD

Blood (2014) 124 (21): 4443.

https://doi.org/10.1182/blood.V124.21.4443.4443

Published: 2014

Journal Articles

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Byeong-Bae Park, MD, Jong Gwang Kim, MD,PhD, HyeonSeok Eom, MD,PhD, Hyo Jin Kim, MD,PhD, Hyuck Chan Kwon, MD,PhD, Sung Yong Oh, MD, Jung Hun Kang, MD, Suk Joong Oh, MD,PhD, Ho-Jin Shin, MD,PhD, Cheolwon Suh, MD,PhD, Jung Han Kim, MD, Ho Young Kim, MD, Sang Cheol Lee, MD, Kihyun Kim, MD,PhD, Chul W. Jung, MD,PhD, Won Seog Kim, MD,PhD

Blood (2006) 108 (11): 4670.

https://doi.org/10.1182/blood.V108.11.4670.4670

Published: 2006

NARROW

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

CD34+ Cell Count and Disease Free Survival in Patients with Diffuse Large B Cell Lymphoma Who Have Received Autologous Stem Cell Transplantaion

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

A Phase II Study of Brentuximab Vedotin for Relapsed or Refractory CD30-Positive Non-Hodgkin Lymphomas Other Than Anaplastic Large Cell Lymphoma

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

The Absolute Lymphocyte Count Is Associated with the Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Difference of Clinical Parameters between GCB and Non-GCB Subtype DLBCL

Difference of Clinical Parameters between Limited and Advanced Stage DLBCL

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis

Unmet Needs for a Better Treatment in Patients with Peripheral T Cell Lymphoma: Data from a Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Control of Neutrophil Endothelial Transmigration By EC-18 in Chemotherapy Induced Neutropenia

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only